2006
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger
Wild P, Giedl J, Stoehr R, Junker K, Boehm S, van Oers J, Zwarthoff E, Blaszyk H, Fine S, Humphrey P, Dehner L, Amin M, Epstein J, Hartmann A. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. The Journal Of Pathology 2006, 211: 18-25. PMID: 17072825, DOI: 10.1002/path.2075.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAlphapapillomavirusChildChild, PreschoolChromosome AberrationsChromosomes, Human, Pair 9DNA Mismatch RepairDNA Mutational AnalysisDNA, ViralFemaleGene Expression ProfilingGenes, p53HumansImmunohistochemistryIn Situ Hybridization, FluorescenceLoss of HeterozygosityMaleMicrosatellite InstabilityOligonucleotide Array Sequence AnalysisPapillomaPolymerase Chain ReactionReceptor, Fibroblast Growth Factor, Type 3Urologic NeoplasmsUrotheliumConceptsPatients 19 yearsUrothelial neoplasmsUrothelial papillomaMicrosatellite instabilityClinical outcomesHuman papillomavirusTP53 mutationsHigh-grade papillary urothelial carcinomaNIH consensus panelEvidence of diseaseFavorable clinical outcomeLow malignant potentialChromosome arm 9pPapillary urothelial carcinomaComparative genomic hybridizationPapillary urothelial neoplasmHPV positivityYounger patientsMultifocal tumorsUrothelial carcinomaUrothelial tumorsMalignant potentialPolymerase chain reactionConsensus panelKi-67
1998
Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey.
Coffin C, Humphrey P, Dehner L. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Seminars In Diagnostic Pathology 1998, 15: 85-101. PMID: 9606801.Peer-Reviewed Original ResearchConceptsInflammatory myofibroblastic tumorExtrapulmonary sitesAberrant inflammatory responseSoft tissue mesenchymal tumorsLow malignant potentialEpstein-Barr virusSpindle cell sarcomaSpindle cell neoplasmConstitutional symptomsInflammatory hypothesisInflammatory pseudotumorSurgical resectionInflammatory natureLocal recurrenceMyofibroblastic tumorPrognostic categoriesVascular invasionCell sarcomaPathological featuresMalignant potentialInflammatory processPathological diagnosisInflammatory responseCell neoplasmsEmbryonal rhabdomyosarcoma